PTC Therapeutics Inc. buy UBS Group AG
Start price
03.12.24
/
50%
€49.60
Target price
03.12.25
€67.48
Performance (%)
28.02%
End price
04.12.25
€63.50
Summary
This prediction ended on 04.12.25 with a price of €63.50. The prediction had a final performance of 28.02%. UBS_Group_AG has a follow-up prediction for PTC Therapeutics Inc. where he still thinks PTC Therapeutics Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| PTC Therapeutics Inc. | -3.817% | -3.817% | 43.836% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by UBS_Group_AG for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at UBS Group AG from $47.00 to $71.00. They now have a "buy" rating on the stock.
Ratings data for PTCT provided by MarketBeat
In the thread Trading PTC Therapeutics Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€43.60
29.07.25
29.07.25
€68.98
29.07.26
29.07.26
43.35%
07:36
07:36
Stopped prediction by UBS_Group_AG for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€31.00
26.08.24
26.08.24
€42.11
26.08.25
26.08.25
34.19%
27.08.25
27.08.25